Contribution: Industrial Research Assistance Program – Contributions to Firms
Traferox Technologies Inc
$300,000.00
Pancreas ex-vivo support
FY 2024-25 · 2024-10-01
Summary
Traferox will design, manufacture, and validate a system to perform normothermic ex vivo perfusion of the pancreas. In normothermic ex vivo pancreas perfusion, the excised pancreas is perfused with a solution containing red blood cells and maintained at body temperature for several hours in preparation for transplantation. Normothermic ex vivo pancreas perfusion enables detailed functional assessment of the organ and assessment of their suitability for transplant, as well as functional improvement. This project will create a system suitable for preclinical and clinical research.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Mississauga|Mississauga, Ontario, Canada
Recipient Type
For-profit organization
Business Number
717995286
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2025-06-29
Agreement Number
1023909
Agreement Start Date
2024-10-01
Agreement Title
Pancreas ex-vivo support
Agreement Title (French)
Soutien au pancréas ex vivo
Agreement Type
Contribution
Agreement Value
$300,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Traferox will design, manufacture, and validate a system to perform normothermic ex vivo perfusion of the pancreas. In normothermic ex vivo pancreas perfusion, the excised pancreas is perfused with a solution containing red blood cells and maintained at body temperature for several hours in preparation for transplantation. Normothermic ex vivo pancreas perfusion enables detailed functional assessment of the organ and assessment of their suitability for transplant, as well as functional improvement. This project will create a system suitable for preclinical and clinical research.
Description (French)
Traferox concevra, fabriquera et validera un système de perfusion normothermique ex vivo du pancréas. Dans la perfusion ex vivo normothermique du pancréas, le pancréas excisé est perfusé avec une solution contenant des globules rouges et maintenu à la température du corps pendant plusieurs heures en préparation de la transplantation. La perfusion normothermique ex vivo du pancréas permet une évaluation fonctionnelle détaillée de l’organe et une évaluation de leur aptitude à la transplantation, ainsi qu’une amélioration fonctionnelle. Ce projet permettra de créer un système adapté à la recherche préclinique et clinique.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Mississauga--Erin Mills
Federal Riding (French)
Mississauga--Erin Mills
Federal Riding Number
35060
NAICS Code
339110
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
717995286
Recipient City
Mississauga|Mississauga
Recipient Country
CA
Recipient Legal Name
Traferox Technologies Inc
Recipient Postal Code
L5L 5Y7
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2024-2025-Q3-1023909
